Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Trading Statement

27 Sep 2017 07:00

RNS Number : 8921R
Halma PLC
27 September 2017
 

Halma plc

 

Trading Update

 

27 September 2017

 

Trading Update

 

Halma, the leading safety, health and environmental technology group today releases its scheduled Trading Update, relating to trading for the period from 2 April 2017.

 

Halma made good progress in line with the Board's expectations. The improved rates of organic constant currency revenue and profit growth achieved in the second half of the last financial year have continued into the current year. Order intake was ahead of revenue and also ahead of the same period last year.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. Asia Pacific maintained strong growth, with good progress in the UK and Mainland Europe and a steady performance in the USA.

 

The Environmental & Analysis sector performed particularly well, benefitting from strong growth in Asia Pacific and the re-organisation in its Life Science and Research business during the first half of last year.

 

The improved performance achieved by the Process Safety sector in the second half of last year continued. Market diversification and rising demand from the US onshore energy market both contributed to significant growth over the prior year.

 

The Infrastructure Safety sector continued to achieve good growth as greater investment in new product development in recent years contributed towards increasing demand from Asia Pacific and Mainland Europe.

 

The Medical sector also achieved solid revenue growth, although profitability was lower due to increased investment in new product development and sales resources.

 

In August 2017, we announced the acquisitions of Cardios for an initial consideration of R$50m (£12.1m) and CASMED for $4.5m (£3.4m). Both businesses strengthen our Medical sector's blood pressure monitoring technology base, with Cardios also being Halma's first acquisition in Brazil. The integration of both businesses is progressing well.

 

Our M&A pipeline strengthened during the period. We continue to search for businesses in, or adjacent to, all four sectors and the additional sector resources added during 2016 have improved both the quantity and quality of our opportunities.

 

Cash generation was good and the Group's financial position remains strong.

 

The results for the half year ending 30 September 2017 will be released on 21 November 2017.

 

 

 

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

This Trading Update is based on unaudited management accounts information and has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDCUDDBGRL
Date   Source Headline
21st Jun 20072:17 pmRNSDirector/PDMR Shareholding
19th Jun 20077:01 amRNSFinal Results
13th Jun 20072:41 pmRNSHolding(s) in Company
8th Jun 200710:25 amRNSHolding(s) in Company
4th Jun 200710:48 amRNSHolding(s) in Company
4th Jun 200710:15 amRNSNotice of Board Meeting
4th Jun 200710:08 amRNSTotal Voting Rights
30th Apr 20075:13 pmRNSTotal Voting Rights
26th Apr 20077:01 amRNSTrading Statement
30th Mar 200712:48 pmRNSTotal Voting Rights
29th Mar 20075:33 pmRNSTreasury Stock
23rd Mar 200711:16 amRNSHolding(s) in Company
23rd Mar 200710:34 amRNSDirectorate Change
6th Mar 20072:56 pmRNSHolding(s) in Company
6th Mar 200712:43 pmRNSBlocklisting Interim Review
5th Mar 200710:47 amRNSDirector/PDMR Shareholding
27th Feb 20073:40 pmRNSHolding(s) in Company
22nd Feb 20075:47 pmRNSHolding(s) in Company
19th Feb 20072:37 pmRNSDirector/PDMR Shareholding
8th Feb 200710:56 amRNSAcquisition
6th Feb 20073:39 pmRNSHolding(s) in Company
6th Feb 20079:30 amRNSInvestor Visit
1st Feb 20074:21 pmRNSHolding(s) in Company
16th Jan 20072:52 pmRNSTotal Voting Rights
16th Jan 20072:39 pmRNSHolding(s) in Company
18th Dec 20069:34 amRNSTotal Voting Rights
12th Dec 20063:43 pmRNSTreasury Stock
12th Dec 20063:38 pmRNSDirector/PDMR Shareholding
5th Dec 200610:51 amRNSDoc re. Interim Report 2006
5th Dec 20067:00 amRNSInterim Results
27th Nov 20068:55 amRNSAcquisition
20th Nov 20062:24 pmRNSNotice of Results
9th Nov 20064:43 pmRNSHolding(s) in Company
8th Nov 200612:31 pmRNSHolding(s) in Company
31st Oct 20063:30 pmRNSHolding(s) in Company
26th Oct 20067:00 amRNSTrading Statement
18th Oct 200611:22 amRNSHolding(s) in Company
2nd Oct 20062:07 pmRNSDirector/PDMR Shareholding
15th Sep 20063:08 pmRNSShare Plan Treasury Shares
14th Sep 200610:34 amRNSDirector/PDMR Shareholding
11th Aug 20062:59 pmRNSBlocklisting Interim Review
4th Aug 200612:44 pmRNSHolding(s) in Company
4th Aug 200612:37 pmRNSDoc re. AGM 2006 resolutions
2nd Aug 20067:00 amRNSAGM Statement
1st Aug 20064:20 pmRNSHolding(s) in Company
31st Jul 20065:23 pmRNSHolding(s) in Company
25th Jul 20065:31 pmRNSHolding(s) in Company
25th Jul 20061:15 pmRNSAnnual Information Update
18th Jul 20065:38 pmRNSHolding(s) in Company
10th Jul 20063:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.